PCR-based diagnostics Hologic Banking on MDx Acquisitions to Elevate Long-Term Revenue Growth Premium The company has invested revenues from its pandemic testing business to buy assets that are growing faster than its base business. ACMG Presentation Highlights Broad Institute's Massive Expansion of COVID-19 Testing Program The Broad's clinical research sequencing lab now runs 135,000 tests each day and routinely tests more than 100 higher education sites and 40 schools in the state. Scope Fluidics Gets CE Mark for Rapid MRSA MDx Panel The assay runs on the firm's rapid molecular diagnostics instrument, the PCR One, in approximately 15 minutes. German Nucleic Acid Sample Prep Startup Rides COVID-19 Testing, Automation Waves Premium The company's nucleic acid extraction kits have offered labs relief from COVID-19-related shortages of traditional silica-based bind-wash-elute assays. Illumina, Helix Collaborate on CDC-Coordinated Coronavirus Surveillance The partners have already identified cases in the US of the novel, highly transmissible SARS-CoV-2 variant that was first reported in the UK. Sep 15, 2020 Fulgent Genetics Wins Utah COVID-19 Testing Contract Sep 9, 2020 Fulgent Genetics Shares Rise on News of Miami-Dade County Coronavirus Testing Deal Aug 19, 2020 Oppenheimer Initiates Coverage of Fulgent Genetics With Outperform Rating Aug 17, 2020 Fulgent Genetics Opens CLIA-Certified Lab in Houston, Raises Revenue Guidance Aug 6, 2020 SARS-CoV-2 Study Documents Viral Dynamics in Young Adults With or Without Symptoms Aug 5, 2020 Fulgent Genetics Touts Returns on COVID-19 Testing Investment Premium Aug 4, 2020 Fulgent Genetics Revenues More Than Double in Q2, Driven by COVID-19 Testing Jul 31, 2020 NIH Awards $249M to Seven Firms for Rapid Acceleration of COVID-19 Diagnostics Jun 26, 2020 Iowa Startup FBB Biomed Pursues RNA Blood Test to Predict COVID-19 Disease Severity Premium May 20, 2020 Mammoth Biosciences, GSK Developing CRISPR-Based SARS-CoV-2 Diagnostic for Home Testing Premium May 15, 2020 Case Study Shows Power of SARS-CoV-2 Genome Testing to Track Viral Spread, ID Strains Premium May 4, 2020 Fulgent Genetics Q1 Revenues Jump 44 Percent Apr 29, 2020 UCSF, Stanford, CZ Biohub Receive $13.6M to Study Bay Area COVID-19 Spread Apr 16, 2020 UCSF, Mammoth Bio Develop Rapid Coronavirus Diagnostic Using CRISPR-Cas12 Method Mar 25, 2020 Sentinel Diagnostics Looks to Expand Global Influence With SARS-CoV-2 Test Mar 3, 2020 Ubiquitome Pushes Compact PCR System for Decentralized Coronavirus Testing Premium Feb 24, 2020 Luminex Submits Verigene II Respiratory Assay for FDA Clearance Feb 14, 2020 BGI Distributes More Than 230K Coronavirus Test Kits Sep 19, 2019 BioLizard to Develop AI Algorithm for Novigenix Colon Cancer Detection Test Jul 25, 2019 UK Researchers Developing Blood-Based TB DNA Test, Eyeing Broader Screening Premium Load More Breaking News Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel Type 1 Diabetes GWAS, Fine-Mapping Leads to New Genetic Loci, Potential Drug Targets LSU Health Sciences Center Wins $2.4M to Lead SARS-CoV-2 Variant Sequencing Program NanoString Technologies, Parker Institute for Cancer Immunotherapy Partner on Cell Therapy Project BGI Americas Collaborating With Champions Oncology on Proteomic Cancer Research Personal Genome Diagnostics Inks Cancer Genomic Profiling Deal with Duke University Health System The Scan Missed Early Cases A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports. Limited Journal Editor Diversity A survey finds low diversity among scientific and medical journal editors, according to The Scientist. How Much of a Threat? Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned. PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.